Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 28, 2015; 21(12): 3746-3749
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3746
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3746
Figure 1 Improvement in psoriasis vulgaris after anti-epidermal growth factor receptor antibody monotherapy.
A: Clearly demarcated plaques with silver scales are evident before initiation of cetuximab; B: After initiation of cetuximab, psoriasis skin lesions remarkably improved, and only erythema was observed.
Figure 2 Effect of anti-epidermal growth factor receptor antibody on liver metastatic lesions of colon cancer.
A: Enhanced abdominal computed tomography showed metastatic lesions throughout the liver, including in the right posterior segment; B: The best response was partial response, with eventual regrowth.
- Citation: Okamoto K, Maeda H, Shiga T, Shiga M, Dabanaka K, Hanazaki K, Kobayashi M. Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: A potential beneficial effect on psoriasis vulgaris. World J Gastroenterol 2015; 21(12): 3746-3749
- URL: https://www.wjgnet.com/1007-9327/full/v21/i12/3746.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i12.3746